Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FCM vs FCM-R in Previously Treated CLL
NCT00337246Phase 2Completed
- Sponsor
- Cancer Research UK
- Start
- Jul 2005
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in chronic lymphocytic leukemia (CLL), sponsored by Cancer Research UK. Started Jul 2005; status: completed.
02
Drugs
rituximab
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00337246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00337246.